Approval · Notice of Compliance 21632 · 2018
BIOTHRAX: Notice of Compliance 21632
Issued December 13, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 21632
- Date
- December 13, 2018
- Company
- Emergent Biodefense Operations Lansing LlcLansing, Michigan, United States
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BIOTHRAX | Not yet assigned | — |
Medicinal ingredients
- ANTHRAX ANTIGEN FILTRATE 50 MCG per 0.5MG